Apple System Exploited with Claude Mythos AI: Crypto Risks
A security firm reports that researchers used Claude Mythos AI to help build a macOS kernel exploit. The incident spo...
Which Index Funds Are Best For Beginners
Which Index Funds Are Best For Beginners presents straightforward guidance on selecting beginner-friendly, low-cost index funds.
23,892 articles
Biotechnology Stock Nearly Doubled: VIR Insight Today
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
2026 Gamechanger: Century DeAnna Reshapes Real Estate Loans
Century DeAnna Realty capped a five-year growth sprint with a 110% rise in transactions, leveraging culture-driven M&...
Copart (Cprt) 2026 Earnings Outlook: Key Takeaways
Tune into Copart's Q3 2026 earnings transcript and discover what drives the CPRT stock, how margins are holding, and ...
What Happens Ripple Becomes Bank? XRP Market Reacts
Ripple advances toward a national bank charter, triggering headlines and trading shifts for XRP. Experts weigh how wh...
Gibraltar Industries Stock After CEO Purchase: Signals
A big open-market purchase by Gibraltar Industries' CEO has traders buzzing. This article breaks down what the move m...
Broadcom (AVGO) 2026 Earnings: Roadmap, Risks, Opportunities
Broadcom's 2026 earnings outlook hinges on data center demand and enterprise IT budgets. This guide breaks down what ...
Applied Digital Stock Skyrocketed: What Fueled the Rally
A dramatic May rally sent applied digital stock skyrocketed as AI optimism surged. This piece breaks down the drivers...
Anthropic Disables Fable and Mythos After Export Crackdown
Anthropic moved to disable access to its Fable 5 and Mythos 5 models after a U.S. export controls directive barred fo...
Prediction: These Words From Sam Altman That Live on Infamy
AI excitement has investors chasing the next big thing. Yet a cautionary line attributed to Sam Altman still echoes i...
Technologies Director Sells $287,000: What Investors Should Know
Insider moves can reveal a lot about a company's near-term strategy, but they rarely tell the whole story. This guide...
Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status